ACUTA CAPITAL PARTNERS, LLC

Position in TSHA — Taysha Gene Therapies, Inc.

CIK 1582844 REDWOOD CITY, CA

Position in TSHA

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$1,964,404

-$537,144 QoQ

Shares Held

439,464

-3.4% QoQ

Ownership

0.153%

of shares outstanding

% of Portfolio

1.42%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

ACUTA CAPITAL PARTNERS, LLC holds $134,918,104 across 23 Biotechnology names. TSHA ranks #16 (1.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PRAX	Praxis Precision Medicines, Inc.	84,901	$27,354,253
2	TERN	Terns Pharmaceuticals, Inc.	495,772	$26,137,099
3	WHWK	Whitehawk Therapeutics, Inc.	3,410,402	$11,765,886
4	TNGX	Tango Therapeutics, Inc.	441,831	$9,243,104
5	DRUG	Bright Minds Biosciences Inc.	111,996	$8,172,348
6	STRO	Sutro Biopharma, Inc.	269,425	$6,711,376
7	ERAS	Erasca, Inc.	354,575	$5,737,023
8	SRZN	Surrozen, Inc./DE	172,847	$5,035,033

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,964,404	439,464	-3.4%	Shares	Sole	2026-05-15
2025-12-31	$2,501,548	454,827	0.0%	Shares	Sole	2026-02-17
2025-09-30	$1,487,284	454,827	-6.4%	Shares	Sole	2025-11-14
2025-06-30	$1,121,895	485,669	-45.1%	Shares	Sole	2025-08-14
2024-12-31	$1,529,742	884,244	-58.3%	Shares	Sole	2025-02-14
2024-09-30	$4,259,173	2,118,992	-9.1%	Shares	Sole	2024-11-14
2024-06-30	$5,221,298	2,330,937	-30.1%	Shares	Sole	2024-08-14
2024-03-31	$9,566,665	3,333,333	-7.1%	Shares	Sole	2024-05-15
2023-12-31	$6,353,119	3,589,333	-6.2%	Shares	Sole	2024-02-14
2023-09-30	$12,096,246	3,827,926	—	Shares	Sole	2023-11-14
No filing history on record for this holder in this stock.